Breathing limits during exercise in cystic fibrosis patients on ETI
Part of Digestive system, Genetic & congenital, Lungs & breathing clinical trials.
This study measures how often people with cystic fibrosis who take elexacaftor-tezacaftor-ivacaftor (ETI) experience breathing limitations during exercise and what factors are linked to this.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have cystic fibrosis
- You are being treated at the cystic fibrosis centers in Lille or Créteil, France
- You are currently taking elexacaftor-tezacaftor-ivacaftor (ETI) therapy
- You have health insurance (social security) coverage
- You are able to understand the study and give written consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures how antibiotics are processed by the body in people with cystic fibrosis who are taking a combination drug called elexacaftor/tezacaftor/ivacaftor (ETI). Understanding this helps doctors prescribe the right antibiotic doses for patients on this newer treatment.
This study looks at how the triple combination therapy (elexacaftor/tezacaftor/ivacaftor, or ETI) affects your body's metabolism, epigenetics, and gut bacteria in people with cystic fibrosis. It aims to understand the broader health benefits of this treatment.
This study tests whether people with cystic fibrosis who are already on a triple combination CFTR modulator can stay on their treatment without interruptions or problems. It aims to make sure everyone gets the best, most consistent treatment for their CF.
This study tests whether doing remote (home-based) exercise can improve your physical activity levels and heart health if you have cystic fibrosis. You'll be guided through exercises from home, and the researchers will see if this helps your heart and overall well-being.
This study looks at how cystic fibrosis and gene modulator treatments affect the health of your heart and blood vessels. By joining, you'll help researchers understand these effects and potentially improve care for people with CF.
This study tests whether a specific exercise program can improve muscle strength, breathing, and fitness in children with cystic fibrosis who are stable and able to exercise.
Hear when a new Cystic Fibrosis (CF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.